Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lefkowitz

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Radiology|December 21, 2021
Local Extent of Prostate Cancer at MRI versus Prostatectomy Histopathology: Associations with Long-term Oncologic OutcomesAndreas G Wibmer, Ines Nikolovski, Joshua Chaim, et al.
Annals of Surgery|November 13, 2018
Association of MRI T2 Signal Intensity With Desmoid Tumor Progression During Active Observation: A Retrospective Cohort StudyMichael R Cassidy, Robert A Lefkowitz, Niamh Long, et al.
Clinical Genitourinary Cancer|May 26, 2022
MRI-Detectability of Clinically Significant Prostate Cancer Relates to Oncologic Outcomes After ProstatectomyAndreas G Wibmer, Robert A Lefkowitz, Yulia Lakhman, et al.
Academic Radiology|March 20, 2003
Routine editing of trainee-generated radiology reports: effect on style qualityFergus V Coakley, Stefan B Heinze, Clair L Shadbolt, et al.
Cancer Chemotherapy and Pharmacology|October 19, 2010
A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridolMark A Dickson, Manish A Shah, Dana Rathkopf, et al.
Journal of Neurosurgery. Spine|February 7, 2025
Posterior vertebral column resection for recurrent tethered cord syndrome: a 10-year case seriesHarshal A Shah, Miriam M Shao, Brandon A Santhumayor, et al.
The Journal of Urology|November 18, 2020
Oncologic Outcomes after Localized Prostate Cancer Treatment: Associations with Pretreatment Prostate Magnetic Resonance Imaging FindingsAndreas G Wibmer, Joshua Chaim, Yulia Lakhman, et al.
The Oncologist|August 24, 2023
Combined RAF and MEK Inhibition to Treat Activated Non-V600 BRAF-Altered Advanced CancersNaryan Rustgi, Ann Maria, Nicolas Toumbacaris, et al.
Investigational New Drugs|May 13, 2010
A phase I pharmacokinetic study of pulse-dose vorinostat with flavopiridol in solid tumorsMark Andrew Dickson, Dana E Rathkopf, Richard D Carvajal, et al.
Sarcoma|June 16, 2015
Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue SarcomaMark A Dickson, David R D'Adamo, Mary L Keohan, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Radiology|December 21, 2021
Local Extent of Prostate Cancer at MRI versus Prostatectomy Histopathology: Associations with Long-term Oncologic OutcomesAndreas G Wibmer, Ines Nikolovski, Joshua Chaim, et al.
Annals of Surgery|November 13, 2018
Association of MRI T2 Signal Intensity With Desmoid Tumor Progression During Active Observation: A Retrospective Cohort StudyMichael R Cassidy, Robert A Lefkowitz, Niamh Long, et al.
Clinical Genitourinary Cancer|May 26, 2022
MRI-Detectability of Clinically Significant Prostate Cancer Relates to Oncologic Outcomes After ProstatectomyAndreas G Wibmer, Robert A Lefkowitz, Yulia Lakhman, et al.
Academic Radiology|March 20, 2003
Routine editing of trainee-generated radiology reports: effect on style qualityFergus V Coakley, Stefan B Heinze, Clair L Shadbolt, et al.
Cancer Chemotherapy and Pharmacology|October 19, 2010
A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridolMark A Dickson, Manish A Shah, Dana Rathkopf, et al.
Journal of Neurosurgery. Spine|February 7, 2025
Posterior vertebral column resection for recurrent tethered cord syndrome: a 10-year case seriesHarshal A Shah, Miriam M Shao, Brandon A Santhumayor, et al.
The Journal of Urology|November 18, 2020
Oncologic Outcomes after Localized Prostate Cancer Treatment: Associations with Pretreatment Prostate Magnetic Resonance Imaging FindingsAndreas G Wibmer, Joshua Chaim, Yulia Lakhman, et al.
The Oncologist|August 24, 2023
Combined RAF and MEK Inhibition to Treat Activated Non-V600 BRAF-Altered Advanced CancersNaryan Rustgi, Ann Maria, Nicolas Toumbacaris, et al.
Investigational New Drugs|May 13, 2010
A phase I pharmacokinetic study of pulse-dose vorinostat with flavopiridol in solid tumorsMark Andrew Dickson, Dana E Rathkopf, Richard D Carvajal, et al.
Sarcoma|June 16, 2015
Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue SarcomaMark A Dickson, David R D'Adamo, Mary L Keohan, et al.
Pageof 9